An HLA-DRB1*0402 derived peptide (HV3 65-79) prevents collagen-induced arthritis in HLA-DQ8 transgenic mice

Human Immunology

Volumn 60, Issue 7, 1999, Pages 575-582

  Das, Pritam ^a   Bradley, David S ^a   Geluk, Annemieke ^c   Griffiths, Marie M ^d   Luthra, Harvinder S ^b   David, Chella S ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

IL 10; MHC; Rheumatoid arthritis; Shared epitope; TCR

Indexed keywords

HLA DQ ANTIGEN; HLA DR ANTIGEN; SYNTHETIC PEPTIDE; COLLAGEN; HLA DQ8 ANTIGEN; HLA-DRB1 ANTIGEN; INTERLEUKIN 10; PEPTIDE;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG EFFECT; HLA SYSTEM; IMMUNIZATION; IMMUNOMODULATION; IMMUNOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RHEUMATOID ARTHRITIS; TRANSGENIC MOUSE; AMINO ACID SEQUENCE; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; DRUG ADMINISTRATION; GENETICS; HUMAN; IMMUNOLOGY; INCIDENCE; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; ANIMALS; ARTHRITIS, RHEUMATOID; COLLAGEN; DRUG ADMINISTRATION SCHEDULE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INCIDENCE; INTERLEUKIN-10; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PEPTIDES;

EID: 0032586666     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00059-2     Document Type: Article

References (39)

1. Rheumatoid Arthritis: Etiology, Diagnosis and Treatment. In Utsinger PD and Ehrlich GE (eds): Philadelphia, PA, JP Lippincott Co., 1985.
2. Stastny P., Ball E., Kahn M., Olsen N., Pincus T., Gao X. HLA-DR4 and other genetic markers in rheumatoid arthritis. Br J Rheumatol. 27:1988;132.
3. Winchester R. Genetic determination of susceptibility and severity in rheumatoid arthritis. Ann Intern Med. 117:1992;869.
4. Larsen B.A., Alderice C.A., Howkins D., Martin J.R., Mitchell D.M., Sheridan D.P. Protective HLA-DR phenotypes in rheumatoid arthritis. J Rheumatol. 16:1989;455.
5. Barber L.D., Bal V., Lamb J.R., O'Hehir R.E., Yendel Y., Hancock R.J.T., Lecher R.I. Contribution of T cell receptor contacting and peptide binding residues of the class II molecule HLA-DR4 Dw10 to serologic and antigen-specific T cell recognition. Hum Immunol. 32:1991;110.
6. Ollier W., Thomson W. Population genetics of Rheumatoid Arthritis. Rheum Dis Clin North Am. 18:1992;741.
7. Cairns J.S., Curtsinger J.M., Dahl C.A., Freeman S., Alter B.J., Bach F.H. Sequence polymorphisms of HLA DR beta 1 alleles relating to T cell recognized determinants. Nature (Lond). 317:1985;166.
8. Gregersen P.K., Silver J., Winchester R.J. The shared epitope hypothesis an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis . Arthritis Rheum. 30:1987;1205.
9. Todd J.A., Bell J.I., McDevitt H.O. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature (Lond). 329:1987;599.
10. Baisch J.M., Weeks T., Giles R., Hoover M., Stastny P., Capra J.D. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med. 322:1990;1836.
11. Doherty D.G., Vaughan R.W., Donaldson P.T., Mowat A.P. HLA DQA, DQB and DRB genotyping by oligonucleotide analysis distribution of alleles and haplotypes in British caucasoids . Hum Immunol. 34:1992;53.
12. Maeda H., Juji T., Mitsui H., Sonosaki H., Okitsu K. HLA-DR4 and rheumatoid arthritis in Japanese people. Ann Rheum Dis. 40:1981;299.
13. Gonzalez A., Nicovani S., Massardo L., Bull P., Rodriguez L., Jacobelli S. Novel genetic markers of rheumatoid arthritis in Chilean patients, by DR serotyping and restriction fragment length polymorphism analysis. Arthritis Rheum. 35:1992;282.
14. Brown J.H., Jardetzky T.S., Gorga J.C., Stern L.J., Urban R.G., Strominger J.L., Wiley D.C. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature (Lond). 364:1993;33.
15. Stern L., Brown J.H., Jardetzky T.S., Gorga J.C., Urban R.G., Strominger J.L., Wiley D.C. Crystal structure of the human class II histocompatibility protein HLA-DR1 complexed with an influenza virus peptide. Nature (Lond). 368:1994;215.
16. Taneja V., Mehra N.K., Chandershekaran A.N., Ahuja R.K., Singh Y.N., Malaviya A.N. HLA-DR4-DQw8 but not DR4-DQw7 haplotypes occur in Indian patients with rheumatoid arthritis. Rheumatol Int. 11:1992;251.
17. Singal D.P., D'Souza N., Reid B., Bensen W.G., Kassam Y.B., Adachi J.D. HLA-DQ beta-chain polymorphism in HLA-DR4 haplotypes associated with rheumatoid arthritis. Lancet. i:1987;1118.
18. Lanchbury J.S., Sakkas L.I., Marsh S.G., Bodmer J.G., Welsh K.I., Panayi G.S. HLA-DQ beta 3 1 allele is a determinant of susceptibility to DR4-associated rheumatoid arthritis . Hum Immunol. 26:1989;59.
19. Nabozny G.H., Baisch J.M., Cheng S., Cosgrove D., Griffiths M.M., Luthra H.S., David C.S. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis a novel model for human polyarthritis . J Exp Med. 183:1996;27.
20. d transgene on collagen-induced arthritis. J Exp Med. 180:1994;1559.
21. Gonzalez-Gay M.A., Zanelli E., Krco C.J., Nobozny G.H., Hanson J., Griffiths M.M., Luthra H.S., David C.S. Polymorphism of the MHC class II Eb gene determines the protection against collagen-induced arthritis. Immunogenetics. 42:1995;35.
22. Zanelli E., Krco C.J., Baisch J.M., Cheng S., David C.S. Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis. Proc Natl Acad Sci USA. 93:1996;1814.
23. Zanelli E., Gonzalez-Gay M.A., David C.S. Could HLA-DRB1 be the protective locus in rheumatoid arthritis? Immunol Today. 16:1995;274.
24. Bradley D.S., Nabozny G.H., Cheng S., Zhou P., Griffiths M.M., Luthra H.S., David C.S. HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. J Clin Invest. 100:1997;2227.
25. Griffiths M.M., Eichwald E.J., Martin J.H., Smith C.B., DeWitt C.W. Immunogenetic control of experimental type II collagen induced arthritis. Arthritis Rheum. 24:1981;781.
26. Wooley P.H., Luthra H.S., Stuart J.M., David C.S. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med. 154:1981;688.
27. Geluk A., van Meijgaarden K.E., Southwood S., Oseroff C., Drijfhout J., de Vries R.R.P., Ottenhoff T.H.M., Sette A. HLA-DR3 molecules can bind peptides carrying two alternative specific submotifs. J Immunol. 152:1994;5742.
28. Geluk A., van Meijgaarden K.E., Drijfhout J., Ottenhoff T.H.M. CLIP binds to HLA class II using methionine based allele dependent motifs as well as allele independent supermotifs. Mol Immunol. 32:1995;975.
29. k transgene . J Immunol. 153:1994;2758.
30. Wicker L.S., Chen S., Nepom G.T., Elliott J.F., Freed D.C., Bansal A., Zheng S., Herman A., Lernmark A., Petersen L.B., Rothbard J.B., Cummings R., Whiteley P.J. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. J Clin Invest. 98:1996;2597.
31. Seki N., Sudo Y., Yoshiyoka T., Sugihara S., Fugitsu T., Sakuma S., Ogawa T., Hamaoka T., Senoh H., Fugiwara H. Type II collagen induced arthritis. I. Induction and perpetuation of arthritis requires synergy between humoral and cell-mediated immunity. J Immunol. 140:1988;1477.
32. Abbas A.K., Burnstein H.J., Bogen S.A. Determinants of helper T cell-dependent antibody production. Semin Immunol. 5:1993;441.
33. Macatonia S.E., Doherty T.M., Knight S.C., O'Garra A. Differential effect of IL-10 on dendritic cell induced T cell proliferation and IFN-γ production. J Immunol. 150:1993;3755.
34. Segal B.M., Dwyer B.K., Shevach E.M. An interleulin (IL)-10/IL12 immunoregulatory circuit controls susceptibility to autoimmune disease. J Exp Med. 187:1998;537.
35. Ding L., Linsley P.S., Huang L.Y., Germain R.N., Shevach E.M. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol. 15:1993;1224.
36. Malefyt D.W., Ysell H., de Vries J.E. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol. 150:1993;4754.
37. Aichele P., Brduscha-Reim K., Oehen S., Odermatt B., Zinkernagel R.M., Hengartner H., Pircher H. Peptide antigen treatment of näive-immune mice antigen-specific tolerance versus immunopathology . Immunity. 6:1997;519.
38. Nicholson L.B., Greer J.M., Sobel R.A., Lees M.B., Kuchroo V.K. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity. 3:1995;397.
39. Moudgil K.D., Chang T.T., Erodat H., Chen A.M., Gupta R.S., Brahn E., Sercarz E.E. Diversification of T cell responses to carboxy-terminal determinants within the 65-Kd heat shock protein is involved in the regulation of autoimmune arthritis. J Exp Med. 185:1997;1307.